Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Interest Coverage Ratio (2020 - 2025)

Historic Interest Coverage Ratio for Rani Therapeutics Holdings (RANI) over the last 6 years, with Q3 2025 value amounting to 10.01.

  • Rani Therapeutics Holdings' Interest Coverage Ratio fell 1342.41% to 10.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 12.19, marking a year-over-year decrease of 2248.41%. This contributed to the annual value of 10.59 for FY2024, which is 1850.89% up from last year.
  • As of Q3 2025, Rani Therapeutics Holdings' Interest Coverage Ratio stood at 10.01, which was down 1342.41% from 11.98 recorded in Q2 2025.
  • Rani Therapeutics Holdings' 5-year Interest Coverage Ratio high stood at 13362.0 for Q4 2021, and its period low was 252.55 during Q3 2021.
  • Its 5-year average for Interest Coverage Ratio is 755.9, with a median of 13.31 in 2024.
  • The largest annual percentage gain for Rani Therapeutics Holdings' Interest Coverage Ratio in the last 5 years was 1577548.54% (2021), contrasted with its biggest fall of 47175.42% (2021).
  • Rani Therapeutics Holdings' Interest Coverage Ratio (Quarter) stood at 13362.0 in 2021, then tumbled by 100.18% to 24.31 in 2022, then surged by 57.37% to 10.37 in 2023, then decreased by 28.38% to 13.31 in 2024, then rose by 24.78% to 10.01 in 2025.
  • Its Interest Coverage Ratio was 10.01 in Q3 2025, compared to 11.98 in Q2 2025 and 12.74 in Q1 2025.